Keyphrases
Ablation
100%
Randomized Trial
100%
Catheter Ablation
100%
Cardiomyopathy
100%
Cardioverter-defibrillator Implantation
100%
Monomorphic Ventricular Tachycardia
100%
Hazard Ratio
66%
Cardiovascular Hospitalizations
50%
Implantable Defibrillator
50%
Ventricular Tachycardia Recurrence
50%
Cardiovascular Mortality
33%
Nonischemic Cardiomyopathy
33%
Ablation Therapy
33%
Associated Complications
16%
Clinical Practice Guidelines
16%
Left Ventricular Ejection Fraction
16%
Heart Disease
16%
First-line Therapy
16%
Ischemic Cardiomyopathy
16%
Conventional Therapy
16%
Composite Endpoint
16%
Ventricular Tachycardia
16%
Unmet Medical Need
16%
Prospective Registry
16%
Implantable Cardioverter-defibrillator Shock
16%
Implantable Cardioverter-defibrillator Therapy
16%
Multicenter Randomized Controlled Trial
16%
Ventricular Tachycardia Ablation
16%
Advanced Therapies
16%
Antitachycardia Pacing
16%
Arrhythmogenic Cardiomyopathy
16%
Medicine and Dentistry
Implantable Automatic Defibrillator
100%
Defibrillator
100%
Monomorphic Ventricular Tachycardia
100%
Myocardial Disease
100%
Ablation
100%
Ventricular Tachycardia
55%
Hazard Ratio
44%
Recurrent Disease
33%
Cardiovascular System
33%
Ablation Therapy
22%
Nonischemic Cardiomyopathy
22%
Arm
11%
Randomized Controlled Trial
11%
Combination Therapy
11%
Heart Left Ventricle Ejection Fraction
11%
Clinical Guideline
11%
Ischemic Cardiomyopathy
11%
Shock (Circulatory)
11%
Heart Disease
11%
Antitachycardia Pacing
11%
Advanced Therapy
11%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Ventricle Tachycardia
100%
Monomorphic Ventricular Tachycardia
100%
Myocardial Disease
100%
Recurrent Disease
60%
Nonischemic Cardiomyopathy
40%
Combination Therapy
20%
Randomized Controlled Trial
20%
Heart Disease
20%
Ischemic Cardiomyopathy
20%
Biochemistry, Genetics and Molecular Biology
Ventricular Tachycardia
100%
Implantable Cardioverter-Defibrillator
100%
Heart Left Ventricle Ejection Fraction
11%
Randomized Controlled Trial
11%